Intraoperative Radiation Therapy Market Size and Share: 2031 Key Findings
The Intraoperative Radiation Therapy Market is expected to register a CAGR of 6.3% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Products and Services (Products, Systems/Accelerators, Applicators and After loaders, Treatment Planning Systems, Accessories, and Services). The report is segmented by Technology (Electron IORT, and Intraoperative Brachytherapy). The report is segmented by Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head and Neck Cancer, Colorectal Cancer, Endometrial and Cervical Cancer, Lung Cancer, and Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Intraoperative Radiation Therapy Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Intraoperative Radiation Therapy Market Segmentation
Products and Services- Products
- Systems/Accelerators
- Applicators and After loaders
- Treatment Planning Systems
- Accessories
- Services
- Electron IORT
- Intraoperative Brachytherapy
- Breast Cancer
- Brain Tumor
- Gastrointestinal Cancer
- Head and Neck Cancer
- Colorectal Cancer
- Endometrial and Cervical Cancer
- Lung Cancer
- Others
Strategic Insights
Intraoperative Radiation Therapy Market Growth Drivers- Increase in Cancer Incidence: An ever-increasing number of incidences of cancer worldwide, which is the most significant driving factor in favor of growth of intensive intra-operative radiotherapy (IORT). According to WHO estimates, cancer is now one of the leading causes of global deaths, with millions of fresh cases occurring each year. The benefit of IORT exists in a number of tumors-breast, colorectal, and head and neck cancers. The upsurge in demand for recent technologies in cancer treatment provokes service providers to uptake into use new technologies as well as high-end treatment devices like IORT.
- Technological advancements in IORT devices: Innovations in radiation equipment along with the developing process in treatment planning software are substantially contributing to the growth of the IORT market. Newly developed IORT systems have higher precision and efficiency, which raises the success rate of treatment. Intraoperative radiation therapy would be much more performed by a larger crowd right now with respectively miniaturized and portable radiation therapy devices that are actually being developed directly to be used in the operating room. These developments are therefore making IORT a probable treatment for larger populations of cancer types and patient subgroups, fuelling market growth further.
- Increasing Demand for Minimally Invasive Cancer Therapy: The shifting landscape toward minimally invasive treatments in oncology is driving the uptake of IORT. In contrast, traditional radiation therapy requires many sessions over several weeks and is often not the easiest for the patient. IORT offers a single fraction of targeted radiation at the time of surgery, so it reduces treatment time. This shortening of therapy duration, coupled with this potential for improved outcomes, has made IORT appealing to more care providers to add to their option set.
- Integration of IORT with Other Cancer Therapies: The most dominant trend in the IORT market is the increasingly integrated approach of IORT with other cancer treatment modalities that include surgery, chemotherapy, and conventional radiation therapy. The combination approach has proven to be very effective for complicated cancers as it allows better controls on the tumors and reduced risk of recurrence. It is becoming increasingly common to combine IORT with chemotherapeutic and other adjutant therapies in order to give a patient individualized therapies that optimize the benefits of these treatment modalities.
- Personalized Cancer Treatment: IORT has been personalized even further for an individual by basing it on tumor characteristics and the overall health of an individual, as the world of medicine moves toward personalized medicine for treatment. With the capabilities provided by molecular diagnostics, oncologists now better understand the genetics of tumors, thus more accurately delivering radiation to a patient's tumor during IORT. This new approach in tailoring patient-specific care is likely to expedite IORT's use in the treatment of all types of cancers.
- Growing Application of IORT in Early Cancer Stages: As IORT is increasingly applied in early stages of cancer, especially for breast cancer, patients can receive the targeted radiation dose for their tumor bed at once right after the resection of the tumor. To that end, this technique can potentially minimize dependence on external beam radiotherapy and thus enhance the quality of life and outcomes of the patients. More clinical evidence that is produced regarding the efficacy of IORT for early-stage cancer patients will lead to its increased use for that purpose.
- Synchronous actions with research institutions: The collaboration of IORT device manufacturers with research institutions still holds great potential in further improving the efficacy and applicability of IORT. Companies could go into clinical trials and research studies, developing new IORT treatment protocols that their technology could be helpful in new types of cancers and then promote this technology to use in clinics. Research collaborations could also come up with new biomarkers and treatment combinations that could improve the patient's life.
- New introductions of IORT technology: New IORT technologies are entering the market because of the competition made technological advancement, leaving a great room for any company to invest their effort in designing future generations of IORT systems. These might include robotic-assisted IORT, AI-driven treatment planning, and further advanced radiation delivery systems that improve the effectiveness and accessibility of IORT. Compact, easy-to-use systems would make it possible for smaller hospitals and even outpatient clinics to provide IORT as part of oncology care, thereby expanding markets further.
- Increased Reimbursement and Insurance: Coverage Health systems seeing value in IORT can achieve higher reimbursement rates and greater coverage by insurance programs. That will increase the accessibility of IORT to a wider patients' base and encourage more hospitals and treatment centers to invest in the technology. This will create a more positive environment for its adoption- especially by patients who, if they had to bear the costs alone, would not afford the treatment.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Intraoperative Radiation Therapy Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Intraoperative Radiation Therapy Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Breast Cancer segment, by application, dominated the market in 2023.
Players operating in the market are ZEISS Group, iCAD, Inc., Eckert & Ziegler, Elekta, GMV Innovating Solutions, Sensus Healthcare, Inc., IntraOp Medical, In, Isoray, Inc, Becton, Dickinson and Company, Sordina IORT Technologies
North America region dominated the Intraoperative Radiation Therapy Market market in 2023.
Synchronous actions with research institutions act as a opportunity for growth of the market in forecast period.
The Intraoperative Radiation Therapy Market is estimated to witness a CAGR of 6.3% from 2023 to 2031
The major factors driving the Intraoperative Radiation Therapy Market market are:
1. Increase in Cancer Incidence
2. Technological advancements in IORT devices
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Intraoperative Radiation Therapy Market - By Products and Services
1.3.2 Intraoperative Radiation Therapy Market - By Technology
1.3.3 Intraoperative Radiation Therapy Market - By Application
1.3.4 Intraoperative Radiation Therapy Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTRAOPERATIVE RADIATION THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTRAOPERATIVE RADIATION THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTRAOPERATIVE RADIATION THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. INTRAOPERATIVE RADIATION THERAPY - GLOBAL MARKET OVERVIEW
6.2. INTRAOPERATIVE RADIATION THERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. INTRAOPERATIVE RADIATION THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCTS AND SERVICES
7.1. OVERVIEW
7.2. PRODUCTS AND SERVICES MARKET FORECASTS AND ANALYSIS
7.3. PRODUCTS
7.3.1. Overview
7.3.2. Products Market Forecast and Analysis
7.4. SYSTEMS/ACCELERATORS
7.4.1. Overview
7.4.2. Systems/Accelerators Market Forecast and Analysis
7.5. APPLICATORS AND AFTER LOADERS
7.5.1. Overview
7.5.2. Applicators and After loaders Market Forecast and Analysis
7.6. TREATMENT PLANNING SYSTEMS
7.6.1. Overview
7.6.2. Treatment Planning Systems Market Forecast and Analysis
7.7. ACCESSORIES
7.7.1. Overview
7.7.2. Accessories Market Forecast and Analysis
7.8. SERVICES
7.8.1. Overview
7.8.2. Services Market Forecast and Analysis
8. INTRAOPERATIVE RADIATION THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. ELECTRON IORT
8.3.1. Overview
8.3.2. Electron IORT Market Forecast and Analysis
8.4. INTRAOPERATIVE BRACHYTHERAPY
8.4.1. Overview
8.4.2. Intraoperative Brachytherapy Market Forecast and Analysis
9. INTRAOPERATIVE RADIATION THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. BREAST CANCER
9.3.1. Overview
9.3.2. Breast Cancer Market Forecast and Analysis
9.4. BRAIN TUMOR
9.4.1. Overview
9.4.2. Brain Tumor Market Forecast and Analysis
9.5. GASTROINTESTINAL CANCER
9.5.1. Overview
9.5.2. Gastrointestinal Cancer Market Forecast and Analysis
9.6. HEAD AND NECK CANCER
9.6.1. Overview
9.6.2. Head and Neck Cancer Market Forecast and Analysis
9.7. COLORECTAL CANCER
9.7.1. Overview
9.7.2. Colorectal Cancer Market Forecast and Analysis
9.8. ENDOMETRIAL AND CERVICAL CANCER
9.8.1. Overview
9.8.2. Endometrial and Cervical Cancer Market Forecast and Analysis
9.9. LUNG CANCER
9.9.1. Overview
9.9.2. Lung Cancer Market Forecast and Analysis
9.10. OTHERS
9.10.1. Overview
9.10.2. Others Market Forecast and Analysis
10. INTRAOPERATIVE RADIATION THERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Intraoperative Radiation Therapy Market Overview
10.1.2 North America Intraoperative Radiation Therapy Market Forecasts and Analysis
10.1.3 North America Intraoperative Radiation Therapy Market Forecasts and Analysis - By Products and Services
10.1.4 North America Intraoperative Radiation Therapy Market Forecasts and Analysis - By Technology
10.1.5 North America Intraoperative Radiation Therapy Market Forecasts and Analysis - By Application
10.1.6 North America Intraoperative Radiation Therapy Market Forecasts and Analysis - By Countries
10.1.6.1 United States Intraoperative Radiation Therapy Market
10.1.6.1.1 United States Intraoperative Radiation Therapy Market by Products and Services
10.1.6.1.2 United States Intraoperative Radiation Therapy Market by Technology
10.1.6.1.3 United States Intraoperative Radiation Therapy Market by Application
10.1.6.2 Canada Intraoperative Radiation Therapy Market
10.1.6.2.1 Canada Intraoperative Radiation Therapy Market by Products and Services
10.1.6.2.2 Canada Intraoperative Radiation Therapy Market by Technology
10.1.6.2.3 Canada Intraoperative Radiation Therapy Market by Application
10.1.6.3 Mexico Intraoperative Radiation Therapy Market
10.1.6.3.1 Mexico Intraoperative Radiation Therapy Market by Products and Services
10.1.6.3.2 Mexico Intraoperative Radiation Therapy Market by Technology
10.1.6.3.3 Mexico Intraoperative Radiation Therapy Market by Application
10.2. EUROPE
10.2.1 Europe Intraoperative Radiation Therapy Market Overview
10.2.2 Europe Intraoperative Radiation Therapy Market Forecasts and Analysis
10.2.3 Europe Intraoperative Radiation Therapy Market Forecasts and Analysis - By Products and Services
10.2.4 Europe Intraoperative Radiation Therapy Market Forecasts and Analysis - By Technology
10.2.5 Europe Intraoperative Radiation Therapy Market Forecasts and Analysis - By Application
10.2.6 Europe Intraoperative Radiation Therapy Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Intraoperative Radiation Therapy Market
10.2.6.1.1 Germany Intraoperative Radiation Therapy Market by Products and Services
10.2.6.1.2 Germany Intraoperative Radiation Therapy Market by Technology
10.2.6.1.3 Germany Intraoperative Radiation Therapy Market by Application
10.2.6.2 France Intraoperative Radiation Therapy Market
10.2.6.2.1 France Intraoperative Radiation Therapy Market by Products and Services
10.2.6.2.2 France Intraoperative Radiation Therapy Market by Technology
10.2.6.2.3 France Intraoperative Radiation Therapy Market by Application
10.2.6.3 Italy Intraoperative Radiation Therapy Market
10.2.6.3.1 Italy Intraoperative Radiation Therapy Market by Products and Services
10.2.6.3.2 Italy Intraoperative Radiation Therapy Market by Technology
10.2.6.3.3 Italy Intraoperative Radiation Therapy Market by Application
10.2.6.4 Spain Intraoperative Radiation Therapy Market
10.2.6.4.1 Spain Intraoperative Radiation Therapy Market by Products and Services
10.2.6.4.2 Spain Intraoperative Radiation Therapy Market by Technology
10.2.6.4.3 Spain Intraoperative Radiation Therapy Market by Application
10.2.6.5 United Kingdom Intraoperative Radiation Therapy Market
10.2.6.5.1 United Kingdom Intraoperative Radiation Therapy Market by Products and Services
10.2.6.5.2 United Kingdom Intraoperative Radiation Therapy Market by Technology
10.2.6.5.3 United Kingdom Intraoperative Radiation Therapy Market by Application
10.2.6.6 Rest of Europe Intraoperative Radiation Therapy Market
10.2.6.6.1 Rest of Europe Intraoperative Radiation Therapy Market by Products and Services
10.2.6.6.2 Rest of Europe Intraoperative Radiation Therapy Market by Technology
10.2.6.6.3 Rest of Europe Intraoperative Radiation Therapy Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Intraoperative Radiation Therapy Market Overview
10.3.2 Asia-Pacific Intraoperative Radiation Therapy Market Forecasts and Analysis
10.3.3 Asia-Pacific Intraoperative Radiation Therapy Market Forecasts and Analysis - By Products and Services
10.3.4 Asia-Pacific Intraoperative Radiation Therapy Market Forecasts and Analysis - By Technology
10.3.5 Asia-Pacific Intraoperative Radiation Therapy Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Intraoperative Radiation Therapy Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Intraoperative Radiation Therapy Market
10.3.6.1.1 Australia Intraoperative Radiation Therapy Market by Products and Services
10.3.6.1.2 Australia Intraoperative Radiation Therapy Market by Technology
10.3.6.1.3 Australia Intraoperative Radiation Therapy Market by Application
10.3.6.2 China Intraoperative Radiation Therapy Market
10.3.6.2.1 China Intraoperative Radiation Therapy Market by Products and Services
10.3.6.2.2 China Intraoperative Radiation Therapy Market by Technology
10.3.6.2.3 China Intraoperative Radiation Therapy Market by Application
10.3.6.3 India Intraoperative Radiation Therapy Market
10.3.6.3.1 India Intraoperative Radiation Therapy Market by Products and Services
10.3.6.3.2 India Intraoperative Radiation Therapy Market by Technology
10.3.6.3.3 India Intraoperative Radiation Therapy Market by Application
10.3.6.4 Japan Intraoperative Radiation Therapy Market
10.3.6.4.1 Japan Intraoperative Radiation Therapy Market by Products and Services
10.3.6.4.2 Japan Intraoperative Radiation Therapy Market by Technology
10.3.6.4.3 Japan Intraoperative Radiation Therapy Market by Application
10.3.6.5 South Korea Intraoperative Radiation Therapy Market
10.3.6.5.1 South Korea Intraoperative Radiation Therapy Market by Products and Services
10.3.6.5.2 South Korea Intraoperative Radiation Therapy Market by Technology
10.3.6.5.3 South Korea Intraoperative Radiation Therapy Market by Application
10.3.6.6 Rest of Asia-Pacific Intraoperative Radiation Therapy Market
10.3.6.6.1 Rest of Asia-Pacific Intraoperative Radiation Therapy Market by Products and Services
10.3.6.6.2 Rest of Asia-Pacific Intraoperative Radiation Therapy Market by Technology
10.3.6.6.3 Rest of Asia-Pacific Intraoperative Radiation Therapy Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Intraoperative Radiation Therapy Market Overview
10.4.2 Middle East and Africa Intraoperative Radiation Therapy Market Forecasts and Analysis
10.4.3 Middle East and Africa Intraoperative Radiation Therapy Market Forecasts and Analysis - By Products and Services
10.4.4 Middle East and Africa Intraoperative Radiation Therapy Market Forecasts and Analysis - By Technology
10.4.5 Middle East and Africa Intraoperative Radiation Therapy Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Intraoperative Radiation Therapy Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Intraoperative Radiation Therapy Market
10.4.6.1.1 South Africa Intraoperative Radiation Therapy Market by Products and Services
10.4.6.1.2 South Africa Intraoperative Radiation Therapy Market by Technology
10.4.6.1.3 South Africa Intraoperative Radiation Therapy Market by Application
10.4.6.2 Saudi Arabia Intraoperative Radiation Therapy Market
10.4.6.2.1 Saudi Arabia Intraoperative Radiation Therapy Market by Products and Services
10.4.6.2.2 Saudi Arabia Intraoperative Radiation Therapy Market by Technology
10.4.6.2.3 Saudi Arabia Intraoperative Radiation Therapy Market by Application
10.4.6.3 U.A.E Intraoperative Radiation Therapy Market
10.4.6.3.1 U.A.E Intraoperative Radiation Therapy Market by Products and Services
10.4.6.3.2 U.A.E Intraoperative Radiation Therapy Market by Technology
10.4.6.3.3 U.A.E Intraoperative Radiation Therapy Market by Application
10.4.6.4 Rest of Middle East and Africa Intraoperative Radiation Therapy Market
10.4.6.4.1 Rest of Middle East and Africa Intraoperative Radiation Therapy Market by Products and Services
10.4.6.4.2 Rest of Middle East and Africa Intraoperative Radiation Therapy Market by Technology
10.4.6.4.3 Rest of Middle East and Africa Intraoperative Radiation Therapy Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Intraoperative Radiation Therapy Market Overview
10.5.2 South and Central America Intraoperative Radiation Therapy Market Forecasts and Analysis
10.5.3 South and Central America Intraoperative Radiation Therapy Market Forecasts and Analysis - By Products and Services
10.5.4 South and Central America Intraoperative Radiation Therapy Market Forecasts and Analysis - By Technology
10.5.5 South and Central America Intraoperative Radiation Therapy Market Forecasts and Analysis - By Application
10.5.6 South and Central America Intraoperative Radiation Therapy Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Intraoperative Radiation Therapy Market
10.5.6.1.1 Brazil Intraoperative Radiation Therapy Market by Products and Services
10.5.6.1.2 Brazil Intraoperative Radiation Therapy Market by Technology
10.5.6.1.3 Brazil Intraoperative Radiation Therapy Market by Application
10.5.6.2 Argentina Intraoperative Radiation Therapy Market
10.5.6.2.1 Argentina Intraoperative Radiation Therapy Market by Products and Services
10.5.6.2.2 Argentina Intraoperative Radiation Therapy Market by Technology
10.5.6.2.3 Argentina Intraoperative Radiation Therapy Market by Application
10.5.6.3 Rest of South and Central America Intraoperative Radiation Therapy Market
10.5.6.3.1 Rest of South and Central America Intraoperative Radiation Therapy Market by Products and Services
10.5.6.3.2 Rest of South and Central America Intraoperative Radiation Therapy Market by Technology
10.5.6.3.3 Rest of South and Central America Intraoperative Radiation Therapy Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INTRAOPERATIVE RADIATION THERAPY MARKET, KEY COMPANY PROFILES
13.1. ZEISS GROUP
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ICAD, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ECKERT AND ZIEGLERELEKTA AB
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GMV INNOVATING SOLUTIONS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SENSUS HEALTHCARE, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. INTRAOP MEDICAL, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ISORAY, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BECTON, DICKINSON AND COMPANY
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SORDINA IORT TECHNOLOGIES
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. ZEISS Group
2. iCAD, Inc.
3. Eckert & Ziegler
4. Elekta
5. GMV Innovating Solutions
6. Sensus Healthcare, Inc.
7. IntraOp Medical, Inc.
8. Isoray, Inc
9. Becton, Dickinson and Company
10. Sordina IORT Technologies
11. Varian Medical Systems, Inc.
12. SeeDos Ltd.
13. IsoAid LLC
14. Ariane Medical Systems Ltd.
15. Panacea Medical Technologies Pvt. Ltd.
16. Salutaris Medical Devices
17. Brainlab AG
18. RaySearch Laboratories
19. REMEDI Co., Ltd.
20. Merit Medical Systems Inc.
21. Xstrahl Medical
22. DOSIsoft SA
23. Huiheng Medical
24. Sun Nuclear Corporation
25. Theragenics Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For